Rekah Pharmaceutical Industry Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
REKA
IL0010810096
Pharmaceuticals
Sales 2022 | 292M 76.8M 105M | Sales 2023 | 322M 84.49M 115M | Capitalization | 169M 44.32M 60.53M |
---|---|---|---|---|---|
Net income 2022 | -2M -525K -718K | Net income 2023 | -6M -1.58M -2.15M | EV / Sales 2022 | 1.1 x |
Net Debt 2022 | 145M 38.2M 52.17M | Net Debt 2023 | 166M 43.72M 59.72M | EV / Sales 2023 | 1.04 x |
P/E ratio 2022 |
-85.5
x | P/E ratio 2023 |
-24.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 93-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 18-10-31 |
Director/Board Member | 78 | 93-08-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15-04-14 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15-04-14 |
Avraham Bigger
CHM | Chairman | 77 | 15-04-14 |
1st Jan change | Capi. | |
---|---|---|
+17.35% | 71.39B | |
+2.39% | 25.1B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-3.38% | 3.93B | |
-2.61% | 3.86B |